InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results

Core Viewpoint - InspireMD, Inc. is set to release its fourth quarter and full year 2025 financial results on March 18, 2026, and will host a conference call to discuss these results and recent highlights [1]. Group 1: Financial Results Announcement - The financial results for the fourth quarter and full year 2025 will be announced on March 18, 2026 [1]. - A conference call and webcast will take place at 8:30 a.m. Eastern Time on the same day to discuss the financial results [1]. Group 2: Company Overview - InspireMD, Inc. develops the CGuard Prime carotid stent system aimed at preventing strokes [1]. - The company utilizes proprietary MicroNet™ mesh technology to establish its products as the industry standard for carotid stenting, focusing on acute results and long-term stroke-free outcomes [3]. - InspireMD's common stock is traded on Nasdaq under the ticker symbol NSPR [3]. Group 3: Investor Information - A live audio webcast and an archive of the recording will be available on InspireMD's corporate website [2]. - Interested participants are encouraged to register more than 15 minutes before the start of the call [2].